Delivery Order SPE2DB24D2205-SPE2DB24FDXPE

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,558.79 firm fixed-price delivery order is for the supply of 4,566,813,975 tablets of the drug Albendazole 200 mg. The contract has an ultimate completion date of January 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,643.82 firm fixed-price delivery order is for the supply of 4,564,909,932 units of 200 mg Albendazole tablets. The contract has a completion date of June 17, 2024 and was awarded on June 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide a variety of medical products and supplies. The $1,044.59 firm fixed-price delivery order covers the procurement of 4,567,274,514 units of 200 mg Albendazole tablets. The contract has an ultimate completion date of February 18, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,094.03 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,567,356,680 units of Albendazole 200 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,043.18 firm fixed-price delivery order is for the supply of 4,566,651,274 units of Albendazole 200 mg tablets, with a completion date of December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,703.50 firm fixed-price delivery order is for the supply of 4,566,420,803 units of the drug Albendazole 200 mg tablets, with a completion date of November 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, identified as SPE2DB20D7066|SPE2DB24FC2DP, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,196.04 Firm Fixed Price delivery order is for the supply of 4,564,593,528 units of Albendazole 200 mg tablets. The contract has a period of performance through May 15, 2024 and was awarded on May 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $5,258.40 firm fixed price delivery order is for the supply of Albendazole tablets. The contract has no set-aside designation and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award, valued at $13,280.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and held by AmerisourceBergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of 4,562,545,777 units of Albendazole 200 mg tablets to support military healthcare programs. The contract is a Firm Fixed Price arrangement with an ultimate completion date of October 23, 2023 and a ceiling value...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDXPE
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,268.12 firm fixed-price delivery order is for the supply of 4,565,265,127 units of Albendazole 200 mg tablets. The contract has an ultimate completion date of July 29, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 5/17/25, 10:14 AM